NCT05346276View on ClinicalTrials.gov

68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

December 13, 2024

Study Completion Date

December 13, 2024

Conditions
PET/CThLAG-3TUMOR
Interventions
DIAGNOSTIC_TEST

68Ga-DOTA-hLAG-3 PET/CT

Each participant receives a single intravenous injection of 68Ga-DOTA-hLAG-3, and undergo PET/CT imaging within the specified time.

Trial Locations (1)

361000

The First affiliated hospital of xiamen university, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER